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MaOBJECTIVES This study sought to summarize the evidence on stress myocardial perfusion imaging (MPI) using
cadmium-zinc-telluride (CZT) technology for the diagnosis of obstructive coronary artery disease (CAD). The CZT cameras
are newly introduced, and comparative data with the conventional Anger technology (Anger-MPI) are lacking.
BACKGROUND The diagnostic accuracy of Anger-MPI for detection of angiographically significant CAD is well
established; however, less evidence is available on the diagnostic accuracy of CZT-MPI.
METHODS Clinical studies comparing CZT-MPI and invasive coronary angiography were systematically searched and
abstracted. Calculations of diagnostic accuracy, including sensitivity, specificity, likelihood ratios, and diagnostic odds
ratio, were obtained with fixed and random effects, reporting point estimates and 95% confidence intervals.
RESULTS Based on our search, a total of 16 studies (N ¼ 2,092) were included. The sensitivity of CZT-MPI was 0.84
(95% confidence interval [CI]: 0.78 to 0.89), whereas the specificity of 0.69 (95% CI: 0.62 to 0.76) was significantly
reduced. The positive likelihood ratio was 2.73 (95% CI: 2.21 to 3.39), the negative likelihood ratio was 0.24 (95% CI: 0.17
to 0.31), and the diagnostic odds ratio was 11.93 (95% CI: 7.84 to 17.42). At subgroup and meta-regression analyses, the
diagnostic accuracy between D-SPECT and Discovery cameras was similar (p ¼ 0.711) and not impacted upon by smaller
sample size studies (p ¼ 0.573).
CONCLUSIONS CZT-MPI has satisfactory sensitivity for angiographically significant CAD, but its suboptimal specificity
warrants further development and research. (J Am Coll Cardiol Img 2017;10:787–94) © 2017 by the American College of
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788The primary aim of this report was to eval-
uate the current evidence on the diagnostic
accuracy of CZT-MPI. Thus, we conducted a
systematic review and meta-analysis of the
available published literature (14–16).
METHODS
STUDY DESIGN. This review was prepared in
keeping with The Cochrane Collaboration
recommendations (14,17) and the current
Preferred Reporting Items for SystematicReviews and Meta-Analyses (PRISMA) statement
(Online Table 1S) (18).SEE PAGE 795SEARCH. PubMed was searched for studies reporting
on MPI using CZT–single-photon emission computed
tomography (SPECT) with the following highly sen-
sitive strategy: “(czt OR (cadmium-zinc-telluride) OR
(cadmium AND zinc AND telluride) OR (alcyone OR
dspect OR d-spect)) AND myocardial AND (imaging
OR scintigraphy).” The Cochrane Library was also
searched with the string “cadmium AND zinc AND
telluride AND myocardial.” References of shortlisted
studies were checked for additional studies. Citations
were first screened at the title/abstract level and then
retrieved as full texts if potentially pertinent. Full
texts were then appraised formally according to
explicit selection criteria. No language restriction was
enforced.
SELECTION, ABSTRACTION, AND APPRAISAL. We
included all studies that reported at least 5 patients intions:
e Library
ed
87 citations excluded at the title or abstract level
6 articles excluded after full text inspection
 as full text
e final analysis
for the systematic review.whom both MPI and coronary angiography had been
performed within a clinically reasonable time frame
and provided adequate details to allow extraction of
actual information for true positives, true negatives,
false positives, and false negatives. No formal exclu-
sion criterion was enforced, except for duplicate
reports.
Several design, baseline, procedural, and outcome
features were extracted, including body mass index
(BMI) and prevalence of obesity, as well as type of
CZT-MPI and acquisition protocol (e.g., stress/rest).
Study validity was appraised using the QUADAS
(Quality Assessment of Diagnostic Accuracy Studies)-
2 checklist (19).
STATISTICAL ANALYSIS. Continuous variables are
given as medians and categorical variables as per-
centages. Diagnostic accuracy was described through
sensitivity, specificity, positive likelihood ratio,
negative likelihood ratio, and diagnostic odds ratio,
with summary estimates (and 95% confidence in-
tervals) and corresponding p values for effect [peffect])
with an univariate model (14,20,21).
Our primary analysis used Reitsma bivariate and
proportional hazard models, which are less prone to
bias given the correlation between sensitivity and
false-positive rate (1  specificity) that is typical of
diagnostic studies (14,20,21). The presence of a
threshold effect with potentially biasing effects was
analyzed with the Spearman correlation test (14).
We also used meta-regression utilizing a Reitsma
bivariate model for sensitivity and false-positive rate,
as well as univariate analysis for calculation of diag-
nostic odds ratios. Statistical heterogeneity and
inconsistency were appraised with chi-square test,
Cochran Q test, Higgins I2, and tau2, reporting corre-
sponding p values for heterogeneity (phet). Several
subgroups analyses were conducted to explore po-
tential sources of heterogeneity. Small study effects
were evaluated graphically with funnel plot inspec-
tion and analytically with Deeks and Egger regression
tests (22). All calculations were performed using
Meta-Disc 1.4 (Ramón y Cajal Hospital, Madrid,
Spain), Stata 13 (StataCorp, College Station, Texas),
and R 3.2.3 (R Foundation for Statistical Computing,
Vienna, Austria) (23,24).
RESULTS
SYSTEMATIC REVIEW. From among 109 citations, 22
were identified and reviewed for relevance to our pri-
mary study aim.We then identified a total of 16 studies
eligible for inclusion, encompassing a total of 2,092
patients (median sample size: 110 patients) (Figure 1)
(8,25–39). In particular, Duvall et al. (29,30) reported
TABLE 1 Key Features of Included Studies (All Studies Were Reported in English Scientific Journals)
First Author (Year) (Ref. #) Setting Study Type CZT-SPECT N Age (yrs) Men DM Obesity BMI (kg/m2)
Ben-Haim (2010) (26) Single center Prospective observational D-SPECT 5 65 64% 36% NA 26
Duvall (2011) (29) Single center Retrospective clinical Discovery NM 530c 230 64 69% 40% NA 28
Fiechter (2011) (8) Single center Retrospective clinical Discovery NM/CT 570c 66 63 79% 36% 35% 28
Gimelli (2012) (31) Single center Prospective observational Discovery NM 530c 137 61 74% 28% 10% NA
Ben-Haim (2014) (27) Single center Retrospective clinical D-SPECT 19 62 49% 39% 100% 36
Chowdhury (2014) (28) Single center Retrospective clinical Discovery NM 530c 165 63 52% 16% NA NA
Duvall (2014) (30) Single center Retrospective clinical Discovery NM 530c 115 60 41% 31% NA 29
Goto (2014) (32) Multicenter Retrospective clinical Discovery NM 530c 322 69 73% 41% NA 25
Mouden (2014) (34) Single center Prospective observational Discovery NM/CT 570c 100 66 50% 31% NA 29
Nishiyama (2014) (36) Single center Retrospective clinical Discovery NM 530c 76 69 63% 42% NA 24
Barone-Rochette (2015) (25) Single center Retrospective clinical Discovery NM 530c 104 65 70% 38% 32% 27
Liu (2015) (33) Single center Retrospective clinical Discovery NM 530c 211 59 NA 29% NA 26
Nakazato (2015) (35) Multicenter Retrospective clinical D-SPECT 67 56 50% 41% 100% 42
Perrin (2015) (37) Single center Retrospective clinical D-SPECT 149 62 80% 31% 30% 28
Shiraishi (2015) (39) Single center Retrospective clinical Discovery NM 530c 55 75 25% 40% NA 24
Sharir (2016) (38) Single center Retrospective clinical Discovery NM 530c 271 61 69% 28% NA 27
First Author (Year) (Ref. #) Prior CAD Cohort Index test Comparator
Ben-Haim (2010) (26) 84% Stable CAD Stress Tc/rest Tl dual-isotope MPI Qualitative angiographic analysis (50% cutoff)–ICA within 3 months
Duvall (2011) (29) 53% Stable CAD Stress-only, rest/stress, or
stress/rest Tl or Tc MPI
Qualitative angiographic analysis (70% cutoff)–ICA within 2 months
Fiechter (2011) (8) NA Stable CAD Stress/rest Tc MPI Qualitative angiographic analysis (50% cutoff)–ICA within 3 months
Gimelli (2012) (31) NA Stable CAD Stress/rest Tc MPI Qualitative angiographic analysis (50% cutoff)–ICA within 1 months
Ben-Haim (2014) (27) 35% Stable CAD Stress/rest Tc MPI Qualitative angiographic analysis (70% cutoff)–ICA within 3 months
Chowdhury (2014) (28) 33% Stable CAD Stress/rest Tc MPI Qualitative angiographic analysis (70% cutoff)–ICA within 2 months
Duvall (2014) (30) 16% Acute chest pain Stress-only, rest/stress,
or stress/rest Tc MPI
Qualitative angiographic analysis (unspecified cutoff)–ICA up to
18 months after MPI
Goto (2014) (32) NA Stable CAD Stress/rest Tc MPI Qualitative angiographic analysis (75% cutoff)–ICA within 2 months
Mouden (2014) (34) NA Stable CAD Stress/rest Tc MPI Fractional flow reserve (0.75 cutoff) within 1 day
Nishiyama (2014) (36) NA Stable CAD Stress/rest Tc MPI Qualitative angiographic analysis (50% cutoff)–ICA within 3 months
Barone-Rochette (2015) (25) 51% Stable CAD (no
prior CABG)
Stress Tl/rest Tc dual-isotope MPI Quantitative angiographic analysis (70% cutoff)–ICA within 3 months
Liu (2015) (33) NA Stable CAD Stress/rest Tl MPI Qualitative angiographic analysis (70% cutoff)–ICA within 6 months
Nakazato (2015) (35) NA Stable CAD Rest/stress or stress/rest Tl or Tc MPI Qualitative angiographic analysis (50% cutoff)–ICA within 2 months
Perrin (2015) (37) 55% Stable CAD Stress-only or stress/rest Tc MPI Quantitative angiographic analysis (50% cutoff)–ICA within 3 months
Shiraishi (2015) (39) NA Stable CAD Stress/rest Tl MPI Qualitative angiographic analysis (75% cutoff)–ICA within 1 months
Sharir (2016) (38) NA Stable CAD Stress/rest Tc MPI Qualitative angiographic analysis (70% cutoff)–ICA within 2 months
BMI ¼ body mass index; CAD ¼ coronary artery disease; CZT-SPECT ¼ cadmium-zinc-telluride single-photon emission computed tomography; DM ¼ diabetes mellitus; ICA ¼ invasive coronary
angiography; MPI ¼ myocardial perfusion imaging; NA ¼ not available or applicable; Pts ¼ patients; Tc ¼ Technetium-99m; Tl ¼ thallium-201.
TABLE 1 Continued
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789on 2 different patient cohorts from the same institu-
tion, and the report by Gimelli et al. (31) was selected as
the most recent from the corresponding institution.
Study quality overall was high despite the pragmatic
features of most studies, which were typically char-
acterized by a potential selection bias for coronary
angiography (Online Table 2S). The studies were pub-
lished between 2010 and 2016, and weremostly single-
center retrospective observational reports (Table 1).
Median age of patients was 63 years. Most series
includedmen and overweight-obese patients, with the
obese patients being the sole focus of enrollment in 2
studies. Moreover, diabetics accounted for a sizeableproportion of enrolled patients (average 34% of sub-
jects), and nearly one-half of the patients had prior
coronary artery disease (CAD) (Table 1, Online
Table 3S). The majority of reported patients had stable
CAD (either suspected or known), except for patients
included in the study by Duvall et al. (30), who were
evaluated for acute chest pain. A stress/rest protocol
was used in all studies, and dual isotope administra-
tion was used in 2 (Online Table 4S). The Discovery NM
530c or Discovery NM/CT 570c camera (with Alcyone
technology, GEHealthcare, Haifa, Israel) was used in 12
studies, whereas the D-SPECT (Spectrum Dynamics,
Palo Alto, California) was used in the remaining
TABLE 2 Study-Level Features of Diagnostic Accuracy















Ben-Haim (2010) (26) 4 0 1 0 0.90 0.25 1.20 0.40 3.00
Duvall (2011) (29) 121 38 65 6 0.95 0.37 1.51 0.14 10.99
Fiechter (2011) (8) 44 10 5 7 0.86 0.66 2.49 0.22 11.33
Gimelli (2012) (31) 103 14 10 10 0.91 0.58 2.16 0.16 13.61
Ben-Haim (2014) (27) 7 10 1 1 0.83 0.88 6.67 0.19 35.00
Chowdhury (2014) (28) 74 61 16 14 0.84 0.79 3.96 0.21 19.15
Duvall (2014) (30) 31 37 23 24 0.56 0.61 14.60 0.71 2.05
Goto (2014) (32) 51 187 73 11 0.82 0.72 2.90 0.25 11.42
Mouden (2014) (34) 12 61 19 8 0.60 0.76 2.47 0.53 4.64
Nishiyama (2014) (36) 46 18 4 8 0.85 0.80 4.32 0.19 22.49
Barone-Rochette (2015) (25) 73 13 13 5 0.93 0.50 1.86 0.14 13.36
Liu (2015) (33) 27 130 46 8 0.76 0.74 2.91 0.32 9.08
Nakazato (2015) (35) 31 23 5 8 0.79 0.81 4.15 0.26 15.83
Perrin (2015) (37) 93 26 17 13 0.87 0.60 2.20 0.21 10.49
Shiraishi (2015) (39) 12 32 9 2 0.83 0.77 3.68 0.22 17.11










Values are point estimate (
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7904 studies. Acquisition with both Anger and CZT cam-
eras was performed only in the study by Ben-Haim
et al. (26).
Positive MPI was defined based on stress-only MPI
in 9 studies and using stress and rest MPI in 7 studies.
Significant CAD was defined using qualitative coro-
nary angiography in 13 studies, quantitative coronary
angiography in 2 studies, and invasive fractional flow
reserve in 1 study. Definitions of significant stenosis
were heterogeneous across the studies. Specifically, 8
studies used $70% to 75% diameter stenosis, 6
studies used $50% stenosis, 1 study did not specify
an explicit cutoff, and 1 study used #0.75 fractional
flow reserve threshold for significant CAD. Radiation
exposure was reported in 5 studies. Barone-Rochette
et al. (25) reported an average radiation exposure of
12 mSv from dual-isotope MPI (rest thallium-201 and
stress technetium [Tc]-99m). Fiechter et al. (8) re-
ported an average radiation exposure of 10 mSv using
Tc-99m (with obesity in nearly one-third of patients).
Duvall et al. (30) reported an average radiation
exposure of 32 mSv using Tc-99m in a largely obesePooled Analysis for Diagnostic Accuracy
Reitsma Model (Random Effects) Univariate Analysis (Fixed Effect)
0.84 (0.78–0.89), peffect < 0.001 0.86 (0.84–0.88), peffect < 0.001
0.69 (0.62–0.76), peffect < 0.001 0.70 (0.67–0.73), peffect < 0.001
2.73 (2.21–3.39), peffect < 0.001 2.70 (2.09–3.48), peffect < 0.001
0.24 (0.17–0.31), peffect < 0.001 0.23 (0.16–0.32), peffect < 0.001
11.93 (7.84–17.42), peffect < 0.001 12.59 (8.11–19.54), peffect < 0.001
95% confidence interval).patient subset with an average BMI of 29 kg/m2.
By comparison, lower radiation doses were reported
in populationswith a lower prevalence of obesity, such
as those reported by Gimelli et al. (31) (average dose:
6 mSv) and Perrin et al. (37) (average dose: 5 mSv).
Image acquisition was stress/rest in 12 studies, and
rest/stress and stress-only were used in the other
studies. Image acquisition was obtained in the prone
position only or in the prone and supine positions in 7
studies.
DIAGNOSTIC ACCURACY. Pooled analysis with a
random effects bivariate model yielded the following
calculations: sensitivity ¼ 0.84 (0.78 to 0.89;
peffect<0.001; phet<0.001; I2¼ 76%), specificity¼0.69
(0.62 to 0.76; peffect < 0.001; phet < 0.001; I2 ¼ 82%),
positive likelihood ratio ¼ 2.73 (2.21 to 3.39;
peffect < 0.001; phet < 0.001; I2 ¼ 83%), negative likeli-
hood ratio ¼ 0.24 (0.17 to 0.31; peffect < 0.001;
phet < 0.001; I2 ¼ 74%), and diagnostic odds
ratio ¼ 11.93 (7.84 to 17.42; peffect < 0.001; phet < 0.001;
I2 ¼ 64%) (Tables 2 and 3, Figures 2 and 3, Online
Figure 1S). Findings were mostly similar even though
different models were used, including the univariate
random effects model and the univariate fixed effect
model (Online Figures 2S, 3S, and 4S).
THRESHOLD, PUBLICATION BIAS, META-REGRESSION,
AND ANCILLARY ANALYSES. Several additional ana-
lyses were conducted to explore potential effect
modifiers (Online Tables 5S and 6S). We found no
evidence of threshold effect by computing the
Spearman correlation test between sensitivity and
false positive rate (p ¼ 0.201) (20,21). Similarly, tests
for publication bias were not significant (p ¼ 0.651
with Deeks test and p ¼ 0.573 with Egger tests)
FIGURE 2 Forest Plot of Univariate Analysis for Sensitivity
0 0.2 0.4 0.6 0.8 1
Sensitivity
Sensitivity (95% CI) 
Duvall (2011)  0.95 (0.90-0.98)
Fiechter (2011)  0.86 (0.74-0.94)
Ben-Haim (2014)  0.88 (0.47-1.00)
Chowdhury (2014)  0.84 (0.75-0.91)
Duvall (2014)  0.56 (0.42-0.70)
Goto (2014)  0.82 (0.70-0.91)
Mouden (2014)  0.60 (0.36-0.81)
Nishiyama (2014)  0.85 (0.73-0.93)
Barone-Rochette (2015)  0.94 (0.86-0.98)
Gimelli (2015)  0.91 (0.84-0.96)
Liu (2015)  0.77 (0.60-0.90)
Nakazato (2015)  0.79 (0.64-0.91)
Perrin (2015)  0.88 (0.80-0.93)
Shiraishi (2015)  0.86 (0.57-0.98)
Sharir (2016)  0.89 (0.83-0.94)
Pooled Sensitivity = 0.86 (0.83 to 0.88)
Chi-square = 61.19; df = 14 (p = 0.0000)
Inconsistency (I-square) = 77.1%
Heterogeneity was appraised using the chi-square test, with corresponding degrees of freedom (df) and p value. CI ¼ confidence interval.
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791(Online Figure 5S). Meta-regression was used to
explore for potential effect moderators, including
year of publication, patient characteristics (age, BMI,
and diabetes), definition of positive MPI, and type
of CZT-MPI camera. The meta-regression findingsFIGURE 3 Forest Plot of Univariate Analysis for Specificity
0 0.2 0.4 0.6 0.8 1
Specificity
Heterogeneity was appraised using the chi-square test, with correspondidentified several parameters associated with
improved diagnostic specificity, including recentness
of publication (p ¼ 0.005) as well as application of
quantitative (p ¼ 0.018) or semiquantitative
segmental scoring methods (p ¼ 0.013) for MPISpecificity (95% CI) 
Duvall (2011)  0.37 (0.28-0.47)
Fiechter (2011)  0.67 (0.38-0.88)
Ben-Haim (2014)  0.91 (0.59-1.00)
Chowdhury (2014)  0.79 (0.68-0.88)
Duvall (2014)  0.62 (0.48-0.74)
Goto (2014)  0.72 (0.66-0.77)
Mouden (2014)  0.76 (0.65-0.85)
Nishiyama (2014)  0.82 (0.60-0.95)
Barone-Rochette (2015)  0.50 (0.30-0.70)
Gimelli (2015)  0.58 (0.37-0.78)
Liu (2015)  0.74 (0.67-0.80)
Nakazato (2015)  0.82 (0.63-0.94)
Perrin (2015)  0.60 (0.44-0.75)
Shiraishi (2015)  0.78 (0.62-0.89)
Sharir (2016)  0.83 (0.75-0.89)
Pooled Specificity = 0.70 (0.67 to 0.73)
Chi-square = 84.04; df = 14 (p = 0.0000)
Inconsistency (I-square) = 83.3%
ing degrees of freedom (df) and p value. CI ¼ confidence interval.
PERSPECTIVES
COMPETENCY IN MEDICAL KNOWLEDGE: The
diagnostic accuracy of MPI with conventional Anger
technology to detect CAD is well established, but the
role of the novel CZT technology, which can signifi-
cantly reduce radiation exposure, is not clearly defined.
A comprehensive systematic review and meta-analysis
showed that MPI with CZT has favorable sensitivity in
comparison to invasive coronary angiography. How-
ever, a reduced diagnostic specificity was reported.
TRANSLATIONAL OUTLOOK: MPI with CZT has a
promising role in the diagnostic work-up of suspected
or established CAD, if additional development and
research can identify strategies to improve diagnostic
specificity. Further studies are required to appraise its
diagnostic accuracy in comparison to other noninva-
sive imaging modalities, such as magnetic resonance
imaging, and to gauge its role in risk stratification and
to guide decision making in patients with CAD.
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792interpretation. Additional plots appraising the good-
ness of fit of the model and normality assumption, and
exploring the impact of the most influential studies
and the presence of outlying studies are available
in the Online Appendix, together with additional
subgroup analyses (Online Figures 6S and 7S).
DISCUSSION
Noninvasive stress MPI for evaluation of suspected
ischemia is the mainstay for management of patients
with suspected or established CAD (1,2). The evidence
base is robust and supports the clinical utility of stress
MPI in the diagnostic, prognostic, and therapeutic
work-up of CAD. The conventional Anger cameras for
SPECT-MPI have been in existence for decades (3).
More recently, CZT cameras have been introduced as
an alternative to the conventional Anger technology.
These cameras have been advocated as an effective
means to reduce radiation exposure and acquisition
time for patients undergoing MPI (4). Our analysis
focused on a systematic review and meta-analysis of
the diagnostic accuracy of the new CZT cameras.
Our main results showed that CZT-MPI has satis-
factory sensitivity for significant CAD (84%), results
comparable to prior summary reports using conven-
tional Anger technology. However, the summary
diagnostic specificity for CZT-MPI was reduced to
69% and revealed false-positive findings in nearly
one-third of patients. This high rate of false-positive
findings may reflect issues related to breast attenua-
tion or obesity, which was prevalent in several series.
The evidence on the diagnostic performance of
Anger-SPECT is well established, with current data
yielding estimates for sensitivity ranging between
0.82 and 0.91, and for specificity between 0.70 to 0.90,
depending on clinical history and chosen cutoff for
significant CAD (40). Prior comparative data in pa-
tients undergoing both CZT-SPECT and Anger-SPECT
have shown that both imaging methods have reason-
able concordance measurements, especially when
obese patients are excluded (13). In addition, CZT-MPI,
with its upright imaging, is generally more comfort-
able for patients. However, the ability to image upright
and the tendency for imaging of amainly obese patient
subgroup may result in reduced diagnostic specificity,
as supported by our meta-analytic findings.
Heterogeneity and inconsistency between indi-
vidual studies was substantial, with the following
significant effect modifiers: recentness of publication,
use of segmental or quantitative score, and applica-
tion of stress-only MPI. Currently, 2 types of CZT-MPI
cameras are available for clinical application
including Alcyone technology (Discovery NM 530cand Discovery NM/CT 570c) with multi-pinhole colli-
mation and D-SPECT with parallel-hole collimation
(4–11). Our analysis did not identify significant dif-
ferences based on the type of CZT-MPI camera used in
studies in the published literature.
STUDY LIMITATIONS. This work has several limita-
tions, including those inherent to systematic reviews
and meta-analyses of diagnostic test accuracy
studies. The heterogeneity in study features, pa-
tients, protocols, cameras, and definitions may lead
to inconsistent estimates. Given the study-level
design and the specifics of included studies, no sub-
group analysis focusing on gender was possible.
Finally, image quality was inconsistently reported
and thus could not be appraised in detail.
CONCLUSIONS
MPI with the novel CZT technology has rela-
tively comparable diagnostic sensitivity for
angiographically-significant CAD to Anger-SPECT.
The reduced diagnostic specificity, which resulted in
a high rate of false-positive findings with CZT-MPI,
warrants further research, particularly as it relates
to imaging of obese patients.
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